Pharmaceutical Updates

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9 October 2026 in Kolkata. The...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health...

Gujarat State Pharmacy Council and Indian Pharmacopoeia Commission Launches “Pharmacovigilance & Medicine Safety” Portal

The Gujarat State Pharmacy Council (GSPC), in collaboration with the Indian Pharmacopoeia Commission (IPC), has officially launched a dedicated "Pharmacovigilance & Medicine Safety" section...

Immuneel Therapeutics and Tata Memorial Centre Partner to Advance Cell & Gene Therapy in India

Immuneel Therapeutics Pvt. Ltd. has announced a strategic collaboration with the Tata Memorial Centre (TMC) to advance Cell & Gene Therapy (CGT) research and development in India. This...

Maharashtra FDA Bars Sale of Two Cadila Drugs Over Branding Similarity

The Maharashtra Food and Drug Administration (FDA) has barred the sale and distribution of select medicines manufactured by Cadila Pharmaceuticals Ltd, after finding that...

Dr. Reddy’s Announces First-to-Market Launch of Generic Bosulif®️ Tablets in the U.S.

Dr. Reddy’s Laboratories Ltd. has launched Bosutinib Tablets 400mg, a first-to-market generic equivalent of Wyeth LLC’s Bosulif®, in the United States. As a first-to-file product,...

Saint Vincent and the Grenadines Formally Recognizes the Indian Pharmacopoeia, Expanding Global Healthcare Collaboration

In a landmark development for global health diplomacy, India,Saint Vincent and the Grenadines have officially signed a Memorandum of Understanding (MoU) for the formal recognition of...

ICMR Postpones High-Altitude Medicine Centre Launch Due to Heavy Rain

The much-anticipated groundbreaking of the Indian Council of Medical Research's new Centre for High Altitude Medicine and Public Health Research in Keylong, Lahaul & Spiti, will not go ahead as...